VolitionRx Ltd
VNRX
38 hedge funds and large institutions have $12.2M invested in VolitionRx Ltd in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 3 closing their positions.
345% more call options, than puts
Call options by funds: $316K | Put options by funds: $71K
300% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 3
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
12% more funds holding
Funds holding: 34 → 38 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.03% less ownership
Funds ownership: 0.54% → 0.51% (-0.03%)
19% less capital invested
Capital invested by funds: $15.1M → $12.2M (-$2.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$135K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$111K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$105K |
| 4 |
JP Morgan Chase
New York
|
+$79.3K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$63.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$129K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$71.7K |
| 3 |
Morgan Stanley
New York
|
-$32.2K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$31.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$6.7K |
VNRX Hedge Fund Activity: Q1 2023 in Review
38 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2023, worth a combined $12.2M — down 19% from $15.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VNRX positions and 3 closed out — a net gain of 4 holders — while 12 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $135K. The largest seller was Citadel Advisors, cutting an estimated $129K.
- 38 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2023, up from 34 in Q4 2022.
- Funds reported $12.2M of VolitionRx Ltd stock for Q1 2023, down 19% quarter-over-quarter.
- 7 funds opened new VolitionRx Ltd positions in Q1 2023 and 3 closed out, a net change of +4 holders.
- The largest VolitionRx Ltd buyer in Q1 2023 was Susquehanna International Group, an estimated $135K added.
- The largest VolitionRx Ltd seller in Q1 2023 was Citadel Advisors, an estimated $129K sold.
Based on aggregated 13F filings for Q1 2023.